Journal Of Gene Medicine

杂志介绍

Journal Of Gene Medicine杂志介绍

《Journal Of Gene Medicine》是一本以English为主的未开放获取国际优秀期刊，中文名称基因医学杂志，本刊主要出版、报道医学-生物工程与应用微生物领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为3，最新CiteScore 指数为4.8。

本刊近期中国学者发表的论文主要有：

• Vitamin D Mitigates Klebsiella pneumoniae-Induced Pneumonia by Regulating Macrophage Polarization Through miR-223/ACSL3 Axis-Mediated Lipid Metabolism Reprogrammin

  Author: Hu, Jiajia; Lin, Yushen; Guo, Wanrong; Zhang, Jingcong; Wu, Benquan; Wang, Yanhong

• Development of CpG-Depleted CFTR Plasmid-Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Diseas

  Author: Qiu, Bei; Lorino, Maryann; Li, Yinghao; He, Zhonglei; Wang, Xianqing; Wang, Wenxin; Lara-saez, Irene

• NLRC4-Mediated Pyroptosis Was Involved in Coagulation Disorders of Acute Pancreatitis (vol 26, e3683, 2024

  Author: Hu, S.; Lin, T.; Chen, Y.; Guo, Y.; Sun, X.; Shi, L.; Pan, J

• Single-Cell RNA Sequencing and Network Pharmacology Reveal the Potential Role of Oxidative Phosphorylation Inactivation in Diagnosing and Treating Chronic Tendon Injurie

  Author: Niu, Jie-Jie; Wang, Long; Qi, Jia-Chen; Lu, Gui-Jun

英文介绍

Journal Of Gene Medicine杂志英文介绍

The aims and scope of The Journal of Gene Medicine include cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies.

Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivo or in vivo pharmacological studies including animal models, and human clinical trials.

Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged.